🇺🇸 FDA
Pipeline program

Sabin-IPV and DTaP

sIPV/DTaP-2019-02

Approved mab active

Quick answer

Sabin-IPV and DTaP for Vaccination is a Approved program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Vaccination
Phase
Approved
Modality
mab
Status
active

Clinical trials